Ceigall India Limited (BOM:544223)
India flag India · Delayed Price · Currency is INR
262.15
+12.65 (5.07%)
At close: Aug 1, 2025

Verve Therapeutics Revenue

Ceigall India had revenue of 8.31B INR in the quarter ending December 31, 2024, with 19.53% growth. This brings the company's revenue in the last twelve months to 33.69B. In the fiscal year ending March 31, 2024, Ceigall India had annual revenue of 30.29B with 46.48% growth.

Revenue (ttm)
33.69B
Revenue Growth
+46.48%
P/S Ratio
1.36
Revenue / Employee
14.93M
Employees
2,256
Market Cap
45.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202430.29B9.61B46.48%
Mar 31, 202320.68B9.34B82.41%
Mar 31, 202211.34B2.61B29.84%
Mar 31, 20218.73B--